 |
Year
of Care Practical Guide |
| |
The Year of Care programme, a joint venture
supported by Diabetes UK, NHS National Diabetes Support Team, Department
of Health and the Health Foundation, has published "Getting to Grips with the Year of Care: A Practical Guide" 47-page PDF (NDST) |
| |
|
|
Management
of cardiovascular disease in patients with diabetes: the 2008
Canadian Diabetes Association guidelines |
| |
Because cardiovascular disease is the main cause
of mortality among diabetic patients, managing cardiovascular risk
should be a key treatment goal for providers and patients (Canadian
Medical Association) |
| |
|
|
Diabetes
mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation,
and chronic inflammation: confirmation of a syndrome |
| |
The presence of consanguinity in the parents
and similarity of clinical features in the siblings are suggestive
of a novel autoimmune disorder, possibly secondary to autosomal
recessive inheritance (Pediatric Diabetes) |
| |
|
|
New
Zealand to transplant pig cells into humans against diabetes |
| |
New Zealand has given the go-ahead to a controversial
clinical trial involving the transplantation of insulin-producing
pig cells into humans to treat type-1 diabetes (Telegraph, UK) |
| |
|
|
Boehringer
in type-two diabetes drug development |
| |
The company has unveiled a pipeline of novel
oral antidiabetic compounds which are at the phase-two and phase-three
stage of clinical testing (HAYS Pharma) |
| |
|
|
Amylin
Gets $125M from Eli Lilly To Make Once-Weekly Diabetes Drug |
| |
Amylin Pharmaceuticals said today it has scored
a $125 million cash payment from Eli Lilly to manufacture a once-weekly
injectable version of exenatide for diabetes (Xconomy) |
| |
|
